Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Abadi Lestari Indonesia Tbk. (RLCO) vs Tempo Scan Pacific Tbk. (TSPC)

Abadi Lestari Indonesia Tbk.Trading
Tempo Scan Pacific Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Abadi Lestari Indonesia Tbk. dan Tempo Scan Pacific Tbk.: Abadi Lestari Indonesia Tbk. diperdagangkan di Rp3.730 (kapitalisasi pasar 10,41 T, volume 24 jam 1,29 jt), sedangkan Tempo Scan Pacific Tbk. diperdagangkan di Rp2.580 (kapitalisasi pasar 11,68 T, volume 24 jam 429,7 rb). Perbedaan utamanya: Abadi Lestari Indonesia Tbk. dan Tempo Scan Pacific Tbk. berukuran mirip dari sisi kapitalisasi pasar, dan Abadi Lestari Indonesia Tbk. lebih aktif diperdagangkan (1,29 jt vs 429,7 rb). Mana yang lebih baik tergantung tujuan investasimu.

RLCOTSPC
Kapitalisasi Pasar
10,41 T11,68 T
Volume
1,29 jt429,7 rb
Lot
12,9 rb4,3 rb
Perputaran
4,67 M1,11 M
Harga Rata-rata
3.617,042.591,65
Nilai Transaksi
4,67 M1,11 M
Harga Ekuilibrium Indikatif
3.7302.580
Volume Ekuilibrium Indikatif
142100

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

RLCO
Lihat detail
TSPC
Lihat detail

Tentang Abadi Lestari Indonesia Tbk.

PT Abadi Lestari Indonesia (the Entity) was established based on Notarial Deed No. 166 of Siti Nurul Hidajah, S.H., M.Kn., Notary in Bojonegoro, dated August 11, 2014. The Entity started its commercial operations in 2014. PT Abadi Lestari Indonesia is the parent entity, whereas Edwin Pranata is the ultimate beneficial owner of the group.

Selengkapnya di halaman RLCO

Tentang Tempo Scan Pacific Tbk.

PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.

Selengkapnya di halaman TSPC